key: cord-0862982-a4ybjza1
authors: nan
title: Erythema multiforme after SARS-CoV-2 messenger RNA vaccination
date: 2021-12-01
journal: QJM
DOI: 10.1093/qjmed/hcab303
sha: bcab3f4a6e1a85197d8aa5984ca949b17661b431
doc_id: 862982
cord_uid: a4ybjza1

nan

reported although underreporting may be partially responsible for the apparent paucity of cases, given the tremendous number of COVID-19 vaccinations that have been administered globally. [2] [3] [4] [5] Cutaneous reactions due to COVID-19 mRNA vaccines in areas distant from the injection site have occurred in about 2% of vaccine recipients, but more importantly, 83% of individuals with a cutaneous reaction after the first vaccination may receive their second dose without a recurrence of the symptoms, as in the present case. 6 Clinicians should be aware of the diversity of cutaneous reactions due to COVID-19 mRNA vaccines and should inform and reassure patients with an initial skin reaction that they may safely receive their second vaccination.

Photographs 

Consent to publish the details of the case was obtained from the patient. 

Erythema multiforme: recognition and management

Erythema multiforme after CoronaVac vaccination

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases

Cutaneous reactions after SARS-COV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases

European Medicines Agencyj COVID-19 vaccine safety update COMIRNATY BioNTech Manufacturing GmbH

Incidence of cutaneous reactions after messenger RNA COVID-19 vaccines

A-G) Round, well-defined papules with a target-like appearance (yellow arrows) distributed symmetrically on the acral extremities

We thank Mr James R. Valera for his assistance with editing the manuscript.Conflict of interest. None declared.